Read More Pharma Industry News ADX‑629 : Aldeyra Therapeutics kicks off atopic dermatitis phase 2 trial American biotech company Aldeyra Therapeutics said that it has enrolled the first patient in a phase 2 clinical… byPallavi MadhirajuApril 9, 2023